ADVFN
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,243.76
      -0.40%
      US Tech 100
      22,240.00
      -0.13%
      Dow Jones
      44,023.29
      0.00%
      Brent Oil
      67.665
      -0.98%
      Bitcoin
      118,886.37
      0.93%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Acadia Pharmaceuticals Inc (ACAD)

      7. Acadia Pharmaceuticals Inc (ACAD) Financials

      Acadia Pharmaceuticals Inc

      Acadia Pharmaceuticals Inc (ACAD)

      NASDAQ
      22.01
      0.12
      (0.55%)
      Closed July 15 4:00PM
      15 min delayed - Upgrade to Realtime
      22.01
      0.00
      ( 0.00% )
      Pre Market: 8:03AM
      15 min delayed - Upgrade to Realtime

      Acadia Pharmaceuticals Inc (ACAD) Financials

      Acadia Pharmaceuticals Inc Financial Summary

      The current ACAD market cap is 3.68B. The company's latest EPS is USD 1.3531 and P/E is 16.27.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 205.83M241.96M250.4M259.6M244.32M
      Operating Income 15.21M30.44M31.64M6.99M19.29M
      Net Income 16.56M33.39M32.77M143.74M18.99M
      Year End December 30 2024 20202021202220232024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 441.76M484.15M517.24M726.44M957.8M
      Operating Income -286.59M-170.44M-223.6M-73.38M84.28M
      Net Income -281.58M-167.87M-215.98M-61.29M226.45M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 855.1M914.1M976.87M1.19B1.13B
      Total Liabilities 391.06M397.4M399.69M454.96M367.13M
      Total Equity 464.04M516.7M577.18M732.79M765.24M
      Year End December 30 2024 20202021202220232024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 782.62M700.12M587.81M748.96M1.19B
      Total Liabilities 155.61M159.23M187.4M317.2M454.96M
      Total Equity 627.01M540.89M400.41M431.76M732.79M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 29.08M54.09M117.34M157.72M20.32M
      Investing -14.04M-70.23M-152.69M-30.54M-124.05M
      Financing 1.04M4.61M4.88M6.85M1.84M
      Year End December 30 2024 20202021202220232024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -136.17M-125.66M-114.04M16.7M157.72M
      Investing 192.51M-71.1M73.24M32M-30.54M
      Financing 81M18.16M8.2M25.13M6.85M

      Stats and Ratios

      Market Cap 3.68B
      Price to Earnings Ratio 16.27
      Price to Sales Ratio 3.85
      Price to Cash Ratio 11.53
      Price to Book Ratio 5.03
      Dividend Yield -

      Share Statistics

      Shares Outstanding 167.36M
      Average Volume (1 week) 1.96M
      Average Volume (1 Month) 2.2M
      52 Week Change 21.80%
      52 Week High 25.23
      52 Week Low 13.40
      Spread (Intraday) 0.72 (3.2%)

      Company Info

      Company Name Acadia Pharmaceuticals Inc
      Address 251 little falls drive
      wilmington, delaware 19808
      Website https://www.acadia-pharm.com
      Industry pharmaceutical preparations (2834)

      Your Recent History

      NASDAQ
      ACAD
      Acadia Pharmaceuticals
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads